Alnylam Pharmaceuticals Inc. (ALNY) Social Stream



Alnylam Pharmaceuticals Inc. (ALNY): $269.95

3.96 (-1.45%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

B

Add ALNY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#31 of 329

in industry

ALNYLAM PHARMACEUTICALS INC (ALNY) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ALNY.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-19 17 $275 $108 $200 $195.71 2.19%
2021-11-22 18 $275 $108 $200 $195.71 2.19%
2021-12-29 19 $275 $108 $202.5 $195.71 3.47%
2022-01-11 19 $275 $108 $203.85 $195.71 4.16%
2022-01-18 19 $275 $108 $203.3 $195.71 3.88%
2022-01-23 19 $350 $108 $208.3 $195.71 6.43%
2022-01-28 18 $350 $108 $208.2 $195.71 6.38%
2022-02-10 18 $350 $109 $208.65 $195.71 6.61%
2022-02-14 16 $350 $103 $212.052 $195.71 8.35%
2022-02-22 16 $350 $103 $214.166 $195.71 9.43%
2022-03-10 16 $350 $103 $214.631 $195.71 9.67%
2022-04-04 15 $350 $103 $211.277 $195.71 7.95%
2022-04-12 15 $400 $103 $214.055 $195.71 9.37%
2022-04-19 15 $400 $103 $214.277 $195.71 9.49%
2022-04-25 15 $400 $103 $214.277 $195.71 9.49%
2022-04-28 15 $400 $103 $212.5 $195.71 8.58%
2022-05-02 15 $430 $96 $212.444 $195.71 8.55%
2022-06-06 15 $430 $96 $211.888 $195.71 8.27%
2022-06-15 16 $430 $96 $211.888 $195.71 8.27%
2022-06-22 16 $430 $98 $212.333 $195.71 8.49%
2022-07-22 18 $430 $97 $210.157 $195.71 7.38%
2022-07-29 18 $430 $97 $209.631 $195.71 7.11%
2022-08-03 18 $430 $97 $207.842 $195.71 6.2%
2022-08-04 19 $430 $155 $230.055 $195.71 17.55%
2022-08-13 19 $430 $155 $233.117 $195.71 19.11%
2022-08-22 19 $430 $155 $231.5 $195.71 18.29%
2022-09-17 19 $430 $155 $236.5 $195.71 20.84%
2022-10-02 19 $430 $155 $237.888 $195.71 21.55%
2022-10-03 19 $430 $155 $240.058 $195.71 22.66%
2022-10-07 18 $430 $155 $240.058 $195.71 22.66%
2022-10-12 18 $430 $155 $239.941 $195.71 22.6%
2022-10-21 18 $430 $155 $239.882 $195.71 22.57%
2022-10-24 18 $430 $142 $238.882 $195.71 22.06%
2022-10-28 18 $430 $142 $238.352 $195.71 21.79%
2022-10-31 20 $430 $142 $239.684 $195.71 22.47%
2022-11-02 20 $415 $142 $238.894 $195.71 22.07%
2022-12-07 20 $415 $145 $239.052 $195.71 22.15%
2022-12-19 20 $415 $145 $242.105 $195.71 23.71%
2022-12-23 20 $415 $145 $244.263 $195.71 24.81%
2023-01-16 20 $415 $144 $244.21 $195.71 24.78%
2023-01-23 20 $415 $143 $244.157 $195.71 24.75%
2023-01-25 20 $415 $143 $244.684 $195.71 25.02%
2023-01-27 20 $415 $143 $244.736 $195.71 25.05%
2023-02-08 20 $415 $143 $248.888 $195.71 27.17%
2023-02-21 21 $415 $143 $251.789 $195.71 28.65%
2023-02-24 22 $415 $143 $252.25 $195.71 28.89%
2023-02-26 22 $415 $136 $250.75 $195.71 28.12%
2023-03-03 22 $415 $136 $250.55 $195.71 28.02%
2023-03-31 22 $415 $136 $250.19 $195.71 27.84%
2023-04-24 22 $415 $136 $250.428 $195.71 27.96%
2023-05-05 23 $415 $136 $249.045 $195.71 27.25%
2023-05-08 23 $415 $136 $248.818 $195.71 27.14%
2023-06-06 23 $415 $136 $249.954 $195.71 27.72%
2023-07-24 22 $415 $136 $252.523 $195.71 29.03%
2023-07-26 22 $405 $140 $252.238 $195.71 28.88%
2023-08-04 22 $405 $140 $251.523 $195.71 28.52%
2023-08-07 22 $405 $141 $250.571 $195.71 28.03%
2023-08-08 23 $405 $141 $250.142 $195.71 27.81%
2023-09-18 23 $405 $141 $252.65 $195.71 29.09%
2023-09-29 24 $405 $134 $250.523 $195.71 28.01%
2023-10-10 24 $405 $125 $241.409 $195.71 23.35%
2023-10-11 24 $395 $125 $236.045 $195.71 20.61%
2023-10-16 24 $395 $125 $234.545 $195.71 19.84%
2023-10-17 25 $395 $125 $233.863 $195.71 19.49%
2023-11-03 25 $395 $125 $230.217 $195.71 17.63%
2023-11-06 25 $395 $135 $229.913 $195.71 17.48%
2023-11-15 25 $395 $135 $229.434 $195.71 17.23%
2023-12-14 24 $395 $135 $224.454 $195.71 14.69%

The Trend in the Analyst Price Target


Over the past 18 months, ALNY's average price target has gone up $12.12.

Over the past 48 weeks, ALNY's average upside potential has been 29.09%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-16 20 415 144 244.210 235.53 3.69%
2023-06-06 22 415 136 252.523 192.96 30.87%
2023-08-07 22 405 141 250.571 184.29 35.97%
2023-10-11 24 395 125 236.045 167.82 40.65%
2023-11-03 25 395 125 230.217 167.35 37.57%

ALNY Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.71 14 3 7 0 0 24

The Trend in the Broker Recommendations


ALNY's average broker recommendation rating worsened by 0.07 over the prior 39 weeks.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ALNY as an investment opportunity.

  • ALNYLAM PHARMACEUTICALS INC's variance in analysts' estimates is lower than -7659.6% of all US stocks.
  • ALNYLAM PHARMACEUTICALS INC's number of analysts covering the stock is greater than 8054.38% of Pharmaceutical Products stocks.
  • ALNYLAM PHARMACEUTICALS INC's average analyst price target is greater than 8004.85% of Pharmaceutical Products stocks.
  • In terms of how ALNYLAM PHARMACEUTICALS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 1883.02% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to ALNYLAM PHARMACEUTICALS INC are NKTR, IONS, and SRPT.

Is ALNY a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!